Clinical Watch: November 2018
In October 2018, the FDA approved an expanded indication of the HPV vaccine Gardasil 9® to include females and males aged 27–45 years.
In this issue of Clinical Watch, we discuss the expanded use for Gardasil®. We suggest criteria for a new class of drugs used to prevent migraine attacks and review a study evaluating factors influencing antibiotic prescribing for viral infections. Lastly, we review the utilization of decongestants in children younger than 7 years.
For more information about our solutions, please visit conduent.com/pharmacysolutions.